Document is current
Any future updates will be listed below
-
Authors
Wesevich, Austin https://orcid.org/0000-0001-5202-1231
He, Gong
Tomczyk, Greg
Reid, Pankti https://orcid.org/0000-0002-7645-0919
- License Information
-
More Information
Article History
Accepted: 15 March 2023
First Online: 6 April 2023
Declarations
:
: The University of Chicago Institutional Review Board determined this study was exempt from further review as it is of minimal risk and comprised of deidentified survey data.
: No authors had conflict of interest relevant to this study. PR has a patent pending regarding the use of interleukin 6 axis inhibitors for viral infection associated pneumonitis.
